GlaxoSmithKline (GSK) announced the incorporation of its pneumococcal vaccine into the Kenyan national immunisation programme. Kenya is the first African country to receive pneumococcal vaccines through the innovative financing mechanism known as the Advance Market Commitment (AMC), which is designed to bring heavily discounted vaccines to children living in the world’s poorest countries. At a […]
Dispute over pneumococcal vaccine initiative
The Lancet, Volume 374, Issue 9705, Pages 1879 – 1880, 5 December 2009 doi:10.1016/S0140-6736(09)62078-X The Global Alliance for Vaccines and Immunisation is at loggerheads with experts critical of the financing mechanism that it administers for pneumococcal vaccines. Ann Danaiya Usher reports. The US$1·5 billion Advance Market Commitment (AMC) for pneumococcal vaccines was officially launched in […]
